Altimmune - ALT - Share chat

Altimmune (NASDAQ: ALT) is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating treatment for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).

Is this still at clinical stage . If not has there been any favorable results because I’m seeing a steady decline & not sure whether to cut my losses . Any advice or information would be welcome . Thanks

In my opinion @Wakey67 this is good stock to buy and sit on, just ride the wave. It’s current price of $7.67 is a good buy on Friday it was up 9.5% over 7 Days up 20.22% and over the Month up a massive 219.34%, So looking pretty good from my Side. As I said Just My personal Opinion